CIDE-A Antibodies

Santa Cruz Biotechnology delivers a wide array of CIDE-A monoclonal antibodies for advanced research in the field of cell death and apoptosis. CIDE-A Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIDE-A, or Cell Death Inducing DFFA-Like Effector A, plays a critical role in the regulation of apoptosis and is involved in the modulation of cell survival and death pathways. Understanding the function of CIDE-A is essential for elucidating mechanisms underlying various diseases, including cancer and neurodegenerative disorders. The study of CIDE-A can provide insights into therapeutic targets and strategies for disease intervention. Researchers worldwide utilize CIDE-A monoclonal antibodies to explore cellular mechanisms and pathways related to programmed cell death. Current investigations focus on understanding how CIDE-A influences various cellular processes and its potential role in disease development. CIDE-A research continues to reveal new aspects of cellular regulation and death mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for various diseases.